top
Search terms
Results 1 - 10 of 26 - ordered by :
Pages: 1 2 3
Escardio

There is no specific recommendation regarding the followup of patients after discharge for an acute episode of decompensation by the cardiologist or primary care physician. (2) Currently there are ...

Date : 24/09/2018
Escardio

Prof. Mills says, “The trial found that implementation of a high-sensitivity cTnl using the 99th centile as the diagnostic threshold increased the frequency of patients with myocardial injury; ...

Date : 29/08/2018
Escardio

“Contrary to what has been believed for decades,” says Dr. Mente, “the Prospective Urban Rural Epidemiology (PURE) study revealed that a high-carbohydrate diet increases the risk of ...

Date : 29/08/2018
Escardio

Findings from this large, epidemiological cohort study involving 135,335 individuals aged 35 to 70 years from 18 low-, middle- and high-income countries (across North America, Europe, South America, ...

Date : 29/08/2018
Escardio

First randomised trial tests criteria used to diagnose heart attack The Universal Definition of Myocardial Infarction recommends that any increase in troponin above the 99th centile of a healthy ...

Date : 28/08/2018
Escardio

Clinical outcome in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) has progressively improved within the last two decades, in part because of faster diagnosis with invasive ...

Date : 28/08/2018
Escardio

The foods that make up a heart healthy diet for people worldwide may differ from what was previously thought, according to late breaking results from the observational Prospective Urban Rural ...

Date : 28/08/2018
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018
Escardio

Prof. Katus’ 40-year career began with a research fellowship in the laboratory of Edgar Haber at Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA, where he ...

Date : 28/08/2018
Escardio

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart ...

Date : 27/08/2018